177 related articles for article (PubMed ID: 20221446)
1. Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation.
Lindström MS; Nistér M
PLoS One; 2010 Mar; 5(3):e9578. PubMed ID: 20221446
[TBL] [Abstract][Full Text] [Related]
2. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells.
Donati G; Bertoni S; Brighenti E; Vici M; Treré D; Volarevic S; Montanaro L; Derenzini M
Oncogene; 2011 Jul; 30(29):3274-88. PubMed ID: 21399665
[TBL] [Abstract][Full Text] [Related]
3. Genetic inactivation of the transcription factor TIF-IA leads to nucleolar disruption, cell cycle arrest, and p53-mediated apoptosis.
Yuan X; Zhou Y; Casanova E; Chai M; Kiss E; Gröne HJ; Schütz G; Grummt I
Mol Cell; 2005 Jul; 19(1):77-87. PubMed ID: 15989966
[TBL] [Abstract][Full Text] [Related]
4. PHTS, a novel putative tumor suppressor, is involved in the transformation reversion of HeLaHF cells independently of the p53 pathway.
Yu DH; Fan W; Liu G; Nguy V; Chatterton JE; Long S; Ke N; Meyhack B; Bruengger A; Brachat A; Wong-Staal F; Li QX
Exp Cell Res; 2006 Apr; 312(6):865-76. PubMed ID: 16413018
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of TNF-alpha-induced ceramide formation in human glioma cells: P53-mediated oxidant stress-dependent and -independent pathways.
Sawada M; Kiyono T; Nakashima S; Shinoda J; Naganawa T; Hara S; Iwama T; Sakai N
Cell Death Differ; 2004 Sep; 11(9):997-1008. PubMed ID: 15131591
[TBL] [Abstract][Full Text] [Related]
6. Ribosomal protein S27-like, a p53-inducible modulator of cell fate in response to genotoxic stress.
Li J; Tan J; Zhuang L; Banerjee B; Yang X; Chau JF; Lee PL; Hande MP; Li B; Yu Q
Cancer Res; 2007 Dec; 67(23):11317-26. PubMed ID: 18056458
[TBL] [Abstract][Full Text] [Related]
7. Activation of p53 in cervical cancer cells by human papillomavirus E6 RNA interference is transient, but can be sustained by inhibiting endogenous nuclear export-dependent p53 antagonists.
Koivusalo R; Mialon A; Pitkänen H; Westermarck J; Hietanen S
Cancer Res; 2006 Dec; 66(24):11817-24. PubMed ID: 17178878
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of ribosome biogenesis drives cells into senescence through 5S RNP-mediated p53 activation.
Nishimura K; Kumazawa T; Kuroda T; Katagiri N; Tsuchiya M; Goto N; Furumai R; Murayama A; Yanagisawa J; Kimura K
Cell Rep; 2015 Mar; 10(8):1310-23. PubMed ID: 25732822
[TBL] [Abstract][Full Text] [Related]
9. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53.
Niu J; Xu Z; Li XN; Han Z
Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318
[TBL] [Abstract][Full Text] [Related]
10. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells.
Luo Y; Yi Y; Yao Z
Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010
[TBL] [Abstract][Full Text] [Related]
11. Ribosomal protein S9 is a novel B23/NPM-binding protein required for normal cell proliferation.
Lindström MS; Zhang Y
J Biol Chem; 2008 Jun; 283(23):15568-76. PubMed ID: 18420587
[TBL] [Abstract][Full Text] [Related]
12. Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathway.
Wang B; Gao J; Zhao Z; Zhong X; Cui H; Hou H; Zhang Y; Zheng J; Di J; Liu Y
Mol Med; 2022 Sep; 28(1):109. PubMed ID: 36071402
[TBL] [Abstract][Full Text] [Related]
13. Functional ribosome biogenesis is a prerequisite for p53 destabilization: impact of chemotherapy on nucleolar functions and RNA metabolism.
Burger K; Eick D
Biol Chem; 2013 Sep; 394(9):1133-43. PubMed ID: 23640940
[TBL] [Abstract][Full Text] [Related]
14. The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress.
Zhang Q; Zhou X; Wu R; Mosley A; Zeng SX; Xing Z; Lu H
Elife; 2014 Oct; 3():. PubMed ID: 25347121
[TBL] [Abstract][Full Text] [Related]
15. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
16. Loss-of-function genetic screening identifies a cluster of ribosomal proteins regulating p53 function.
Castro ME; Leal JF; Lleonart ME; Ramon Y Cajal S; Carnero A
Carcinogenesis; 2008 Jul; 29(7):1343-50. PubMed ID: 18515283
[TBL] [Abstract][Full Text] [Related]
17. [siRNA-mediated silencing of ClC-2 gene inhibits proliferation of human U-87 glioma cells].
Yang XY; Lai XG; Zhang Y; Pei JM; Yang AG; Zhou SS
Ai Zheng; 2006 Jul; 25(7):805-10. PubMed ID: 16831268
[TBL] [Abstract][Full Text] [Related]
18. The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha.
Gray JP; Davis JW; Gopinathan L; Leas TL; Nugent CA; Vanden Heuvel JP
Toxicol Sci; 2006 Feb; 89(2):535-46. PubMed ID: 16280383
[TBL] [Abstract][Full Text] [Related]
19. RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.
Menendez JA; Lupu R
Int J Mol Med; 2005 Jan; 15(1):33-40. PubMed ID: 15583825
[TBL] [Abstract][Full Text] [Related]
20. Effects of exogenous p53 transfection on the gene expression in the human brain glioma cell line U251.
Shu KX; Li B; Liang YL; Xie YF; Zhang JC; Wei JM
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):126-31. PubMed ID: 16413759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
